Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Liver Fibrosis/NASH”

299 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 299 results

Not applicableUnknownNCT05526274
What this trial is testing

Clinical Epidemiology of NAFLD in Children and Adolescents

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseChildhood Obesity
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina 2,866
Not applicableStudy completedNCT03439189
What this trial is testing

Companion Protocol for Methacetin Breath Test (MBT) in Conatus Protocol IDN-6556-14

Who this might be right for
NASH - Nonalcoholic SteatohepatitisCirrhosisPortal Hypertension
Meridian Bioscience, Inc. 343
Not applicableStudy completedNCT02231333
What this trial is testing

The Efficacy of S-adenosyl Methionine (SAMe) Versus Pentoxiphylline in Patients With Non-alcoholic Steatohepatitis With Fibrosis

Who this might be right for
Non-alcoholic Steatohepatitis
Institute of Liver and Biliary Sciences, India 122
Not applicableLooking for participantsNCT06366425
What this trial is testing

Screening for Chronic Liver Diseases in General Population

Who this might be right for
Fibrosis, Liver
University Hospital, Montpellier 260
Not applicableLooking for participantsNCT03472157
What this trial is testing

Controlled Study Evaluating Bariatric Surgery as a Treatment for Severe NASH With Advanced Liver Fibrosis in Non-severe Obese Patients

Who this might be right for
SurgeryObesityNASH - Nonalcoholic Steatohepatitis+1 more
University Hospital, Lille 100
Not applicableUnknownNCT05802199
What this trial is testing

Quantitative Detection Efficiency of UDFF for Nonalcoholic Fatty Liver Disease

Who this might be right for
Non-alcoholic Fatty Liver Disease
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 300
Not applicableLooking for participantsNCT07294963
What this trial is testing

Impact of Lifestyle Interventions on Cognitive Decline in Non-alcoholic Fatty Liver Disease

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseNeurocognitive Disorders
Khyber Medical University Peshawar 45
Early research (Phase 1)Ended earlyNCT05864391
What this trial is testing

Investigate Safety, Tolerability, and Pharmacokinetics of AZD7503 in Participants With Suspected NASH.

Who this might be right for
Steatohepatitis
AstraZeneca 40
Testing effectiveness (Phase 2)Study completedNCT00885313
What this trial is testing

Effects of Docosahexaenoic Acid (DHA) on Children With Nonalcoholic Fatty Liver Disease (NAFLD)

Who this might be right for
Fatty LiverLiver FibrosisObesity+2 more
Bambino Gesù Hospital and Research Institute 60
Large-scale testing (Phase 3)UnknownNCT02530138
What this trial is testing

The Effect of Synbiotics Supplement on Lipid Profile, Liver Enzymes, Inflammatory Factors and Hepatic Fibrosis in Lean and Normal Weight Patients With Nonalcoholic Fatty Liver

Who this might be right for
Non Alcoholic Steatohepatitis
National Nutrition and Food Technology Institute 42
Post-approval studies (Phase 4)Study completedNCT02210715
What this trial is testing

Raltegravir-based Antiretroviral Versus Maintaining Any Other Antiretroviral Therapy in HIV Mono-infected Patients

Who this might be right for
HIVFatty LiverNonalcoholic Steatohepatitis
McGill University Health Centre/Research Institute of the McGill University Health Centre 31
Early research (Phase 1)Study completedNCT04634149
What this trial is testing

Evaluate the Drug Levels, Safety, and Tolerability of BMS-986036 in Participants With Normal Liver Function and Participants With Moderate and Severe Liver Impairment

Who this might be right for
Moderate Liver ImpairmentSevere Liver Impairment
Bristol-Myers Squibb 16
Not applicableEnrolling By InvitationNCT04066608
What this trial is testing

Prevalence of Advanced Fibrosis in Patients Living With HIV

Who this might be right for
Fatty Liver Disease
Johannes Gutenberg University Mainz 300
Not applicableLooking for participantsNCT03308916
What this trial is testing

Screening At-risk Populations for Hepatic Fibrosis With Non-invasive Markers

Who this might be right for
Liver Diseases, AlcoholicFibrosis
Maja Thiele 6,500
Not applicableUnknownNCT05708560
What this trial is testing

Relationship Between MAFLD and Liver Fibrosis Progression in Patients With Chronic Hepatitis B: a Multicenter Retrospective Cohort Study

Who this might be right for
Hepatitis B, Chronic
Erasmus Medical Center 800
Not applicableStudy completedNCT07021443
What this trial is testing

The Effect of GLP-1 Analogues on Liver Steatosis and Fibrosis in Diabetic and Obese Patients in a Clinical Setting

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Universitair Ziekenhuis Brussel 50
Post-approval studies (Phase 4)Looking for participantsNCT06523530
What this trial is testing

Effect of a GnRH Analog on Hepatic Steatosis

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseaseNonalcoholic Fatty LiverEndometriosis
Aristotle University Of Thessaloniki 62
Not applicableNot Yet RecruitingNCT06623084
What this trial is testing

Integrated Phenotyping of the Gut-plAtelet-Liver AXIS in the Progression of Chronic Liver Disease (iGAL-AXIS)

Who this might be right for
Non-alcoholic Fatty Liver Disease (NAFLD)NASH - Nonalcoholic SteatohepatitisCirrhosis+1 more
Stefania Basili 132
Early research (Phase 1)Study completedNCT04931147
What this trial is testing

A 3-part Study to Evaluate Safety, Tolerability, Food Effect and Drug-drug Interactions of RXC007 in Healthy Volunteers

Who this might be right for
FibrosisInflammationIdiopathic Pulmonary Fibrosis+3 more
Redx Pharma Ltd 90
Testing effectiveness (Phase 2)Study completedNCT03486899
What this trial is testing

Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis

Who this might be right for
Liver FibrosisNonalcoholic Fatty Liver Disease (NAFLD)Nonalcoholic Steatohepatitis
Bristol-Myers Squibb 197
Load More Results